Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.040
-0.060 (-5.45%)
Mar 3, 2026, 4:00 PM EST - Market closed
Standard BioTools Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Standard BioTools stock has a target of 1.35, which predicts a 29.81% increase from the current stock price of 1.04.
Price Target: $1.35 (+29.81%)
Analyst Consensus: Hold
* Price targets were last updated on Nov 5, 2025.
Analyst Ratings
The average analyst rating for Standard BioTools stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $1.55 → $1.35 | Hold | Maintains | $1.55 → $1.35 | +29.81% | Nov 5, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 27, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $2.75 → $2.5 | Strong Buy | Maintains | $2.75 → $2.5 | +140.38% | Oct 31, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $3.5 → $2.75 | Strong Buy | Maintains | $3.5 → $2.75 | +164.42% | Aug 1, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +236.54% | Apr 16, 2024 |
Financial Forecast
Revenue This Year
82.32M
from 85.33M
Decreased by -3.53%
Revenue Next Year
84.48M
from 82.32M
Increased by 2.63%
EPS This Year
-0.16
from -0.20
EPS Next Year
-0.15
from -0.16
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 86.3M | 89.8M | |
| Avg | 82.3M | 84.5M | |
| Low | 78.7M | 79.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.1% | 9.1% | |
| Avg | -3.5% | 2.6% | |
| Low | -7.8% | -3.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.17 | -0.15 | |
| Avg | -0.16 | -0.15 | |
| Low | -0.16 | -0.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.